Accuray (ARAY) Liabilities and Shareholders Equity (2011 - 2026)
Accuray (ARAY) posted quarterly Liabilities and Shareholders Equity of $447.6 million for Q1 2026, up 137.41% year-over-year from $188.5 million in Q1 2025, and up 139.68% quarter-over-quarter from $186.7 million in Q4 2025.
Accuray (ARAY) Liabilities and Shareholders Equity (2011 - 2026) Analysis & Trends
Accuray's Liabilities and Shareholders Equity history runs 16 years deep, the most recent figure standing at $447.6 million for Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity rose 137.41% year-over-year to $447.6 million; the TTM figure through Mar 2026 stood at $1.3 billion (up 101.74% YoY), while the FY2025 annual figure was $470.2 million, up 229.7% from the prior year.
- Liabilities and Shareholders Equity for Q1 2026 stood at $447.6 million, up from $186.7 million in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $470.2 million in Q2 2025, with the low at $90.7 million in Q2 2023.
- The 5-year median for Liabilities and Shareholders Equity is $121.3 million (2023), against an average of $168.8 million.
- The sharpest annual moves came in 2023 and 2025: Liabilities and Shareholders Equity retreated 1.31% in 2023, then soared 229.7% in 2025.
- Accuray's Liabilities and Shareholders Equity stood at $105.4 million in 2022, then gained by 15.12% to $121.3 million in 2023, then surged by 31.08% to $159.0 million in 2024, then rose by 17.44% to $186.7 million in 2025, then jumped by 139.68% to $447.6 million in 2026.
- Business Quant data shows ARAY's Liabilities and Shareholders Equity at $447.6 million in Q1 2026, $186.7 million in Q4 2025, and $197.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 47.93 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 13.87 Bn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 6.46 Bn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 37.25 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 31.04 Bn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Accuray | 36.94 Mn | -2.76 Mn | 25.29 Mn | 447.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 447.60 Mn |
| Dec 31, 2025 | 186.75 Mn |
| Sep 30, 2025 | 197.12 Mn |
| Jun 30, 2025 | 470.24 Mn |
| Mar 31, 2025 | 188.54 Mn |
| Dec 31, 2024 | 159.01 Mn |
| Sep 30, 2024 | 155.06 Mn |
| Jun 30, 2024 | 142.63 Mn |
| Mar 31, 2024 | 114.93 Mn |
| Dec 31, 2023 | 121.31 Mn |
| Sep 30, 2023 | 108.08 Mn |
| Jun 30, 2023 | 90.74 Mn |
| Mar 31, 2023 | 104.17 Mn |
| Dec 31, 2022 | 105.37 Mn |
| Sep 30, 2022 | 92.18 Mn |
| Jun 30, 2022 | 91.94 Mn |
| Mar 31, 2022 | 93.48 Mn |
| Dec 31, 2021 | 84.46 Mn |
| Sep 30, 2021 | 81.93 Mn |
| Jun 30, 2021 | 54.52 Mn |